FPFS
KPTI icon

First Personal Financial Services’s Karyopharm Therapeutics KPTI Stock Holding History

First Personal Financial Services’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-47
Closed -$9K – 815
2018
Q1 		$9K Sell
47
-32
-41% -$6.38K ﹤0.01% 811
2017
Q4 		$11K Hold
79
– – ﹤0.01% 764
2017
Q3 		$13K Hold
79
– – ﹤0.01% 658
2017
Q2 		$11K Hold
79
– – ﹤0.01% 698
2017
Q1 		$15K Hold
79
– – ﹤0.01% 620
2016
Q4 		$11K Buy
+79
New +$10.7K ﹤0.01% 692

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Personal Financial Services's KPTI Position: Q2 2018 in Review

First Personal Financial Services sold out of Karyopharm Therapeutics (KPTI) in Q2 2018, closing a stake of 47 shares — an estimated $9K sold.

First Personal Financial Services first reported a position in KPTI in Q4 2016 and held it in 6 quarters. The position peaked at $15K in Q1 2017. 108 funds tracked by Wall St. Rank hold KPTI as of Q2 2018.

  • First Personal Financial Services reported no remaining Karyopharm Therapeutics position as of Q2 2018 after selling out during the quarter.
  • First Personal Financial Services sold 47 Karyopharm Therapeutics shares in Q2 2018, an estimated $9K.
  • First Personal Financial Services first reported a position in Karyopharm Therapeutics in Q4 2016 and held it in 6 quarters.
  • First Personal Financial Services's Karyopharm Therapeutics position peaked at $15K in Q1 2017.
  • 108 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.